Published in Eur J Clin Invest on May 01, 1996
Deiodinase-mediated thyroid hormone inactivation minimizes thyroid hormone signaling in the early development of fetal skeleton. Bone (2008) 0.92
Role of Thyroid Hormones in Skeletal Development and Bone Maintenance. Endocr Rev (2016) 0.79
Precursor cells from Atlantic salmon (Salmo salar) visceral fat holds the plasticity to differentiate into the osteogenic lineage. Biol Open (2015) 0.76
Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J Pathol (2006) 2.65
Carbimazole and the autoimmune response in Graves' disease. N Engl J Med (1980) 2.62
Mammary and extramammary Paget's disease. J Clin Pathol (2000) 2.62
Computerised updating of clinical summaries: new opportunities for clinical practice and research? BMJ (1988) 2.49
Cyclosporin improves Graves' ophthalmopathy. Lancet (1983) 2.32
Autoimmune thyroid disease: further developments in our understanding. Endocr Rev (1994) 2.19
Autologous chondrocyte implantation versus matrix-induced autologous chondrocyte implantation for osteochondral defects of the knee: a prospective, randomised study. J Bone Joint Surg Br (2005) 2.13
Postpartum thyroid dysfunction. Thyroid (1992) 2.03
Autoimmune thyroid disease: developments in our understanding. Endocr Rev (1984) 1.98
Maturation of the secretion of thyroid hormone and thyroid-stimulating hormone in the fetus. N Engl J Med (1991) 1.78
Thyroid hormone regulation of hepatic genes in vivo detected by complementary DNA microarray. Mol Endocrinol (2000) 1.73
Prediction of outcome in Graves' disease after carbimazole treatment. Q J Med (1986) 1.68
Effects of bromocriptine on pituitary tumour size. Br Med J (1979) 1.64
Characterization and tissue expression of multiple triiodothyronine receptor-auxiliary proteins and their relationship to the retinoid X-receptors. Endocrinology (1993) 1.50
The nadir growth hormone after an octreotide test dose predicts the long-term efficacy of somatostatin analogue therapy in acromegaly. Clin Endocrinol (Oxf) (2005) 1.47
The gene for cherubism maps to chromosome 4p16.3. Am J Hum Genet (1999) 1.43
Macrophage colony stimulating factor (M-CSF) is essential for osteoclast formation in vitro. Biochem Biophys Res Commun (1991) 1.43
The evaluation of patients with a suspected pituitary microadenoma: computer tomography compared to magnetic resonance imaging. Clin Endocrinol (Oxf) (1992) 1.41
Thyroid antibodies are produced by thyroid-derived lymphocytes. Clin Exp Immunol (1982) 1.39
Atypical stromal cells in a hyperplastic endometrial polyp. Histopathology (1995) 1.38
Enzyme-linked immunoassay of monoclonal and serum microsomal autoantibodies. Clin Chim Acta (1984) 1.31
Human osteoclasts derive from CD14-positive monocytes. Br J Haematol (1999) 1.30
Molecular cloning and properties of a full-length putative thyroid hormone receptor coactivator. Endocrinology (1996) 1.28
Expression and hormonal regulation of coactivator and corepressor genes. Endocrinology (1998) 1.27
Prediction of relapse in hyperthyroid Graves' disease. Lancet (1980) 1.27
Ligand-induced recruitment of a histone deacetylase in the negative-feedback regulation of the thyrotropin beta gene. EMBO J (1999) 1.25
The glucocorticoid receptor interacting protein 1 (GRIP1) localizes in discrete nuclear foci that associate with ND10 bodies and are enriched in components of the 26S proteasome. Mol Endocrinol (2001) 1.24
Methimazole inhibits thyroid autoantibody production by an action on accessory cells. Clin Immunol Immunopathol (1983) 1.23
Sites of autoantibody production in rats with thyroiditis. Immunology (1982) 1.21
Postpartum thyroid dysfunction in Mid Glamorgan. Br Med J (Clin Res Ed) (1988) 1.20
The influence of methimazole on thyroglobulin-induced autoimmune thyroiditis in the rat. Endocrinology (1983) 1.19
Who is the ideal candidate for autologous chondrocyte implantation? J Bone Joint Surg Br (2006) 1.19
Somatic mutation of TRbeta can cause a defect in negative regulation of TSH in a TSH-secreting pituitary tumor. J Clin Endocrinol Metab (2001) 1.14
Prostaglandin E2, interleukin 1alpha, and tumor necrosis factor-alpha increase human osteoclast formation and bone resorption in vitro. Endocrinology (1998) 1.14
Macrophage colony-stimulating factor induces substantial osteoclast generation and bone resorption in human bone marrow cultures. Blood (1996) 1.10
Gene expression and serum levels of insulin-like growth factors (IGFs) and IGF-binding proteins in a case of non-islet cell tumour hypoglycaemia. Growth Horm IGF Res (1998) 1.10
Endometrial CD56+ natural killer cells in women with recurrent miscarriage: a histomorphometric study. Hum Reprod (1999) 1.10
The peroxisome proliferator-activated receptor alpha is a phosphoprotein: regulation by insulin. Endocrinology (1996) 1.10
Nuclear cytoplasmic shuttling by thyroid hormone receptors. multiple protein interactions are required for nuclear retention. J Biol Chem (2001) 1.10
Study of the cell biology and biochemistry of cherubism. J Clin Pathol (1998) 1.09
Low frequency of somatic mutations in the FH/multiple cutaneous leiomyomatosis gene in sporadic leiomyosarcomas and uterine leiomyomas. Br J Cancer (2002) 1.08
Reduction in size of a pituitary tumor by bromocriptine therapy. N Engl J Med (1979) 1.08
A case of spurious hypercalcitoninemia: a cautionary tale on the use of plasma calcitonin assays in the screening of patients with thyroid nodules for neoplasia. J Endocrinol Invest (2001) 1.08
Collagen-covered autologous chondrocyte implantation for osteochondritis dissecans of the knee: two- to seven-year results. J Bone Joint Surg Br (2006) 1.08
Analysis of T cell subsets in Graves' disease: alterations associated with carbimazole. Br Med J (Clin Res Ed) (1984) 1.08
Elastofibroma dorsi: management, outcome and review of the literature. J Bone Joint Surg Br (2010) 1.08
Parathyroid hormone-related peptide in normal human fetal development. J Mol Endocrinol (1990) 1.06
Allelotype of uterine leiomyomas. Cancer Genet Cytogenet (1999) 1.06
Aberrant alternative splicing of thyroid hormone receptor in a TSH-secreting pituitary tumor is a mechanism for hormone resistance. Mol Endocrinol (2001) 1.05
Transgenic targeting of a dominant negative corepressor to liver blocks basal repression by thyroid hormone receptor and increases cell proliferation. J Biol Chem (2001) 1.05
Primary tumours of the synovium. A report of four cases of malignant tumour. J Bone Joint Surg Br (2007) 1.05
Detection of osteomalacia in British Asians: a comparison of clinical score with biochemical measurements. Clin Sci (Lond) (1990) 1.04
An immunotoxin of ricin A chain conjugated to thyroglobulin selectively suppresses the antithyroglobulin autoantibody response. Lancet (1983) 1.04
Estrogen and thyroid hormone interaction on regulation of gene expression. Proc Natl Acad Sci U S A (1996) 1.03
Potential therapeutic targets for chordoma: PI3K/AKT/TSC1/TSC2/mTOR pathway. Br J Cancer (2009) 1.03
The influence of cyclosporin a on experimental autoimmune thyroid disease in the rat. Life Sci (1983) 1.02
Evidence for an effect of antithyroid drugs on the natural history of Graves' disease. Clin Endocrinol (Oxf) (1984) 1.01
Endometrial extramedullary haemopoiesis. J Pathol (1995) 1.01
Carbimazole and autoantibody synthesis in Hashimoto's thyroiditis. Br Med J (1980) 1.00
Thyroid hormone response elements differentially modulate the interactions of thyroid hormone receptors with two receptor binding domains in the steroid receptor coactivator-1. J Biol Chem (1998) 1.00
Monoclonal antibodies to the human TSH receptor: epitope mapping and binding to the native receptor on the basolateral plasma membrane of thyroid follicular cells. J Mol Endocrinol (1996) 0.99
MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression. Br J Cancer (2012) 0.99
Agonist-induced endocytosis and recycling of the gonadotropin-releasing hormone receptor: effect of beta-arrestin on internalization kinetics. Mol Endocrinol (1998) 0.99
Thyroid hormones fail to influence experimental autoimmune thyroiditis. Clin Exp Immunol (1982) 0.97
Inhibition of gamma-secretases alters both proliferation and differentiation of mesenchymal stem cells. Cell Prolif (2007) 0.97
A sensitive mutation-specific screening technique for GNAS1 mutations in cases of fibrous dysplasia: the first report of a codon 227 mutation in bone. Histopathology (2007) 0.97
Autoantibodies to the thyroid microsomal/thyroid peroxidase antigen are polyclonal and directed to several distinct antigenic sites. Immunology (1988) 0.97
Unaltered thyroid function in mice responding to a highly immunogenic thyrotropin receptor: implications for the establishment of a mouse model for Graves' disease. Clin Exp Immunol (1995) 0.97
Inhibition of bone resorption by 17beta-estradiol in human bone marrow cultures. J Cell Physiol (1998) 0.96
Do clinical manifestations of resistance to thyroid hormone correlate with the functional alteration of the corresponding mutant thyroid hormone-beta receptors? J Clin Endocrinol Metab (1995) 0.96
Familial autonomic visceral myopathy with degeneration of muscularis mucosae. J Clin Pathol (1988) 0.95
BIM and other BCL-2 family proteins exhibit cross-species conservation of function between zebrafish and mammals. Cell Death Differ (2008) 0.95
Liver transplantation in man--3, Studies of liver function, histology, and immunosuppressive therapy. Br Med J (1969) 0.95
Antithyroid-antibody activity in the snyovial fluid of patients with various arthritides. Lancet (1979) 0.94
The effect of preoperative Lugol's iodine on thyroid blood flow in patients with Graves' hyperthyroidism. Surgery (1987) 0.94
The prevalence and progression of autoimmune thyroid disease in the elderly. Acta Endocrinol (Copenh) (1984) 0.93
Combined segregation and linkage analysis of Graves disease with a thyroid autoantibody diathesis. Am J Hum Genet (1994) 0.93
Chondroid lipoma: correlation of imaging findings and histopathology of an unusual benign lesion. Skeletal Radiol (2004) 0.93
Prediction of domain organisation and secondary structure of thyroid peroxidase, a human autoantigen involved in destructive thyroiditis. FEBS Lett (1990) 0.93
Expression of estrogen receptor-alpha in cells of the osteoclastic lineage. Histochem Cell Biol (1999) 0.92
Lack of coactivator interaction can be a mechanism for dominant negative activity by mutant thyroid hormone receptors. Endocrinology (1998) 0.92
Methimazole and generation of oxygen radicals by monocytes: potential role in immunosuppression. Br Med J (Clin Res Ed) (1984) 0.92
Thyroid microsomal/thyroid peroxidase autoantibodies show discrete patterns of cross-reactivity to myeloperoxidase, lactoperoxidase and horseradish peroxidase. Immunology (1989) 0.91
Macrophage colony stimulating-factor transcripts are differentially regulated in rat bone-marrow by gender hormones. Endocrinology (1999) 0.91
Anti-estrogenic compounds increase prolactin and growth hormone synthesis in clonal strains of rat pituitary cells. Endocrinology (1977) 0.91
Extrathyroidal sites of autoantibody synthesis in Graves' disease. Clin Exp Immunol (1984) 0.91
Altered dopaminergic regulation of thyrotrophin release in patients with prolactinomas: comparison with other tests of hypothalamic-pituitary function. Clin Endocrinol (Oxf) (1981) 0.91
Mapping epitope specificities of monoclonal antibodies to thyroid peroxidase using recombinant antigen preparations. Autoimmunity (1992) 0.91
Acetylcholine receptor antibodies in the elderly and in Down's syndrome. J Neuroimmunol (1985) 0.91
Heat shock proteins and autoimmune thyroid disease; too hot to handle? J Clin Endocrinol Metab (1992) 0.90
Mapping of autoantigenic epitopes on recombinant thyroid peroxidase fragments using the polymerase chain reaction. Autoimmunity (1990) 0.90
Isoform-specific retinoid-X receptor (RXR) antibodies detect differential expression of RXR proteins in the pituitary gland. Endocrinology (1995) 0.90
Familial craniofacial fibrous dysplasia: absence of linkage to GNAS1 and the gene for cherubism. J Med Genet (2000) 0.90
Ovarian androgens protect against bone loss in rats made oestrogen deficient by treatment with ICI 182,780. J Endocrinol (1999) 0.89
Recombinant human thyrotropin for the diagnosis and treatment of a highly functional metastatic struma ovarii. J Clin Endocrinol Metab (2000) 0.89
Identification of an immunodominant region recognized by human autoantibodies in a three-dimensional model of thyroid peroxidase. Endocrinology (2000) 0.89
Immunological and molecular characteristics of the thyroid peroxidase autoantigen. Autoimmunity (1991) 0.89
Transient post-partum thyroid dysfunction and postnatal depression. J Affect Disord (1989) 0.89
Investigation of ethnic neutropenia by assessment of bone marrow colony-forming cells. Acta Haematol (2001) 0.89